Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2012 Apr 21;18(10):1580–1588. doi: 10.1016/j.bbmt.2012.04.012

Table 2.

Multivariate analysis of risk factors for all and lower respiratory tract (LRT) HPIV Infections.

All HPIV LRTI
Factor Risk ratio
(95% CI)
P-value Risk ratio
(95% CI)
P-value
Donor type
 Autologous Ref Ref
 UCB 1.4 (0.8-2.5) 0.31 2.4 (1.0-6.1) 0.06
 Matched related 0.9 (0.6-1.6) 0.80 1.4 (0.6-3.2) 0.41
 Matched unrelated 2.0 (1.1-3.7) 0.03 2.3 (0.8-6.0) 0.11
 Mismatched related 3.2 (1.6-6.3) < 0.01 7.0 (2.7-18.3) < 0.01
 Mismatched unrelated 1.3 (0.6-2.7) 0.55 0.9 (0.3-3.8) 0.98
Gender
 Male Ref Ref
 Female 0.9 (0.7-1.3) 0.75 0.6 (0.3-1.0) 0.04
Diagnosis category
 Lymphoid/malignant 1.2 (0.8-1.8) 0.46 1.0 (0.5-1.9) 0.89
 Myeloid/malignant Ref Ref
 Non-malignant 1.1 (0.7-1.8) 0.66 0.9 (0.4-2.1) 0.89
CMV
 R+ 1.0 (0.7-1.5) 0.80 1.5 (0.9-2.5) 0.15
 R−/D− Ref Ref
 R−/D+ 0.9 (0.4-1.7) 0.66 1.2 (0.5-3.2) 0.66
 Unknown 2.1 (0.6-6.9) 0.22 0.0 (0.0-0.0) 0.98
Age
 Age < 10 years 0.8 (0.5-1.3) 0.42 0.6 (0.3-1.3) 0.18
 Age 10-19 0.5 (0.3-0.9) 0.03 0.5 (0.2-1.1) 0.07
 Age ≥ 20 Ref Ref
Transplant Era
 1974-1992 0.8 (0.5-1.4) 0.56 0.8 (0.4-1.6) 0.47
 1993-2001 0.7 (0.3-1.8) 0.48 0.9 (0.5-1.7) 0.71
 2002-2010 Ref Ref
RIC (risk < 30 days) 0.7 (0.3-1.8) 0.48 0.5 (0.1-1.9) 0.54
RIC (risk ≥ 30 days) 2.1 (1.2-3.5) 0.01 1.4 (0.6-3.1) 0.42
Acute GVHD 1.9 (1.1-3.4) 0.03 2.1 (0.8-5.3) 0.11
Chronic GVHD 6.2 (3.7-10.4) < 0.01 7.1 (3.4-14.8) < 0.01

Abbreviations: GVHD, graft-versus-host disease; Ref, reference group for each comparison category; RIC; reduced intensity conditioning; UCB, umbilical cord blood